2024
Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
Bitar R, Salem R, Finn R, Greten T, Goldberg S, Chapiro J. Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma. Radiology 2024, 313: e232875. PMID: 39560477, PMCID: PMC11605110, DOI: 10.1148/radiol.232875.Peer-Reviewed Original ResearchConceptsManagement of hepatocellular carcinomaHepatocellular carcinomaLocoregional therapyClinical trialsImage-guided locoregional therapiesEnd pointsStages of hepatocellular carcinomaTumor microenvironment mechanismsCatheter-directed therapyCombination of immunotherapyProspective clinical trialImaging end pointsStandard of careAdjuvant settingNovel immunotherapiesCombination therapyTherapy resistanceInterventional radiologistsImmunotherapyDisease stageTherapyDisease evolutionNovel biomarkersCarcinomaMicroenvironment mechanisms
2021
Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative
Puijk R, Ahmed M, Adam A, Arai Y, Arellano R, de Baère T, Bale R, Bellera C, Binkert C, Brace C, Breen D, Brountzos E, Callstrom M, Carrafiello G, Chapiro J, de Cobelli F, Coupé V, Crocetti L, Denys A, Dupuy D, Erinjeri J, Filippiadis D, Gangi A, Gervais D, Gillams A, Greene T, Guiu B, Helmberger T, Iezzi R, Kang T, Kelekis A, Kim H, Kröncke T, Kwan S, Lee M, Lee F, Lee E, Liang P, Lissenberg-Witte B, Lu D, Madoff D, Mauri G, Meloni M, Morgan R, Nadolski G, Narayanan G, Newton I, Nikolic B, Orsi F, Pereira P, Pua U, Rhim H, Ricke J, Rilling W, Salem R, Scheffer H, Sofocleous C, Solbiati L, Solomon S, Soulen M, Sze D, Uberoi R, Vogl T, Wang D, Wood B, Goldberg S, Meijerink M. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative. Radiology 2021, 301: 533-540. PMID: 34581627, DOI: 10.1148/radiol.2021203715.Peer-Reviewed Original ResearchConceptsImage-guided tumor ablationTime-to-event end pointsEnd pointsTumor ablationOncologic end pointsOncological outcome measuresOutcome measuresPatient-reported outcome questionnairesClinical outcome measuresInterventional oncologyConsensus guidelinesClinical trialsHealth economic issuesCancer trialsQuality of lifeConsensus documentOutcomes QuestionnaireDATECANAssess outcomesReport outcomesOncology researchInternational panelTrialsAblationOutcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply